Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/13667

Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells


Vista previa

Ver/Abrir:
 Role_Guillen_JOOT_2021.pdf
2,02 MB
Adobe PDF
Título : Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells
Autor : Guillén Salazar, María Isabel
Tofiño Vian, Miguel
Silvestre Muñoz, Antonio
Castejón, Miguel Ángel
Alcaraz Tormo, María José
Materias: Articulaciones - Enfermedades - Tratamiento.Células madre - Uso terapéutico.Osteoarthritis - Treatment.Joints - Diseases - Treatment.Articulaciones - Inflamación - Tratamiento.Estrés oxidativo.Joints - Inflammation - Treatment.Cartílagos - Enfermedades - Tratamiento.Stem cells - Therapeutic use.Osteoartritis - Tratamiento.Oxidative stress.Cartilage - Diseases - Treatment.
Editorial : Elsevier
Citación : Guillén, M. I., Tofiño-Vian, M., Silvestre, A., Castejón, M.A. & Alcaraz, M.J. (2021). Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells. Journal of Orthopaedic Translation, vol. 30 (sep.), pp. 61–69. DOI: https://doi.org/10.1016/j.jot.2021.08.003
Resumen : Background: Osteoarthritis (OA) is a joint disease characterized by cartilage degradation, low-grade synovitis and subchondral bone alterations. In the damaged joint, there is a progressive increase of oxidative stress leading to disruption of chondrocyte homeostasis. The modulation of oxidative stress could control the expression of inflammatory and catabolic mediators involved in OA. We have previously demonstrated that extracellular vesicles (EVs) present in the secretome of human mesenchymal stem cells from adipose tissue (AD-MSCs) exert antiinflammatory and anti-catabolic effects in OA chondrocytes. In the current work, we have investigated whether AD-MSC EVs could regulate oxidative stress in OA chondrocytes as well as the possible contribution of peroxiredoxin 6 (Prdx6). Methods: Microvesicles (MV) and exosomes (EX) were isolated from AD-MSC conditioned medium by differential centrifugation with size filtration. The size and concentration of EVs were determined by resistive pulse sensing. OA chondrocytes were isolated from knee articular cartilage of advanced OA patients. 4-Hydroxynonenal adducts, IL-6 and MMP-13 were determined by enzyme-linked immunosorbent assay. Expression of Prdx6 and autophagic markers was assessed by immunofluorescence and Western blotting. Prdx6 was downregulated in AD-MSCs by transfection with a specific siRNA. Results: MV and to a lesser extent EX significantly reduced the production of oxidative stress in OA chondrocytes stimulated with IL-1β. Treatment with MV resulted in a dramatic upregulation of Prdx6. MV also enhanced the expression of autophagy marker LC3B. We downregulated Prdx6 in AD-MSCs by using a specific siRNA and then MV were isolated. These Prdx6-silenced MV failed to modify oxidative stress and the expression of autophagy markers. We also assessed the possible contribution of Prdx6 to the effects of MV on IL-6 and MMP-13 production. The reduction in the levels of both mediators induced by MV was partly reverted after Prdx6 silencing. Conclusion: Our results indicate that EVs from AD-MSCs regulate the production of oxidative stress in OA chondrocytes during inflammation. Prdx6 may mediate the antioxidant and protective effects of MV. The translational potential of this article: This study gives insight into the protective properties of EVs from AD-MSCs in OA chondrocytes. Our findings support the development of novel therapies based on EVs to prevent or treat cartilage degradation.
Descripción : Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S2214031X21000656?via%3Dihub
URI : http://hdl.handle.net/10637/13667
Derechos: http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
ISSN : 2214-031X (Electrónico)
Fecha de publicación : 1-sep-2021
Centro : Universidad Cardenal Herrera-CEU
Aparece en las colecciones: Dpto. Farmacia





Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.